Skip to Main Content

Author Details

Efrat Ben-Zeev
Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science
1999
22
15
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
34443335Inhibition of Cysteine Proteases by 6,6'-Dihydroxythiobinupharidine (DTBN) from <i>Nuphar lutea</i>.Molecules2021
33715174Phylogeny and abiotic conditions shape the diel floral emission patterns of desert Brassicaceae species.Plant Cell Environ2021
34443335Inhibition of Cysteine Proteases by 6,6'-Dihydroxythiobinupharidine (DTBN) from <i>Nuphar lutea</i>.Molecules2021
33715174Phylogeny and abiotic conditions shape the diel floral emission patterns of desert Brassicaceae species.Plant Cell Environ2021
31462712The mitochondrial carrier Citrin plays a role in regulating cellular energy during carcinogenesis.Oncogene2020
32442375Nanobodies Targeting Prostate-Specific Membrane Antigen for the Imaging and Therapy of Prostate Cancer.J Med Chem2020
33257760Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).Sci Rep2020
31462712The mitochondrial carrier Citrin plays a role in regulating cellular energy during carcinogenesis.Oncogene2020
33257760Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).Sci Rep2020
32442375Nanobodies Targeting Prostate-Specific Membrane Antigen for the Imaging and Therapy of Prostate Cancer.J Med Chem2020
29535275Pre-equilibrium competitive library screening for tuning inhibitor association rate and specificity toward serine proteases.Biochem J2018
29535275Pre-equilibrium competitive library screening for tuning inhibitor association rate and specificity toward serine proteases.Biochem J2018
28768772A computational combinatorial approach identifies a protein inhibitor of superoxide dismutase 1 misfolding, aggregation, and cytotoxicity.J Biol Chem2017
28768772A computational combinatorial approach identifies a protein inhibitor of superoxide dismutase 1 misfolding, aggregation, and cytotoxicity.J Biol Chem2017
26830231A Novel Allosteric Mechanism of NF-κB Dimerization and DNA Binding Targeted by an Anti-Inflammatory Drug.Mol Cell Biol2016
26830231A Novel Allosteric Mechanism of NF-κB Dimerization and DNA Binding Targeted by an Anti-Inflammatory Drug.Mol Cell Biol2016
27122118Prediction of homoprotein and heteroprotein complexes by protein docking and template-based modeling: A CASP-CAPRI experiment.Proteins2016
27624940Selective Assembly of Na,K-ATPase α2β2 Heterodimers in the Heart: DISTINCT FUNCTIONAL PROPERTIES AND ISOFORM-SELECTIVE INHIBITORS.J Biol Chem2016
27624940Selective Assembly of Na,K-ATPase α2β2 Heterodimers in the Heart: DISTINCT FUNCTIONAL PROPERTIES AND ISOFORM-SELECTIVE INHIBITORS.J Biol Chem2016
27122118Prediction of homoprotein and heteroprotein complexes by protein docking and template-based modeling: A CASP-CAPRI experiment.Proteins2016
26483500Digoxin derivatives with selectivity for the α2β3 isoform of Na,K-ATPase potently reduce intraocular pressure.Proc Natl Acad Sci U S A2015
26483500Digoxin derivatives with selectivity for the α2β3 isoform of Na,K-ATPase potently reduce intraocular pressure.Proc Natl Acad Sci U S A2015
229637661-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase.Bioorg Med Chem Lett2012
229637661-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase.Bioorg Med Chem Lett2012
20337589G protein coupled receptors -in silico drug discovery and design.Curr Top Med Chem2010
20976528Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening.J Comput Aided Mol Des2010
20337589G protein coupled receptors -in silico drug discovery and design.Curr Top Med Chem2010
20976528Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening.J Comput Aided Mol Des2010
15769463Experimental and computational characterization of the dimerization of the PTS-regulation domains of BglG from Escherichia coli.J Mol Biol2005
15981268Docking to single-domain and multiple-domain proteins: old and new challenges.Proteins2005
15769463Experimental and computational characterization of the dimerization of the PTS-regulation domains of BglG from Escherichia coli.J Mol Biol2005
15981268Docking to single-domain and multiple-domain proteins: old and new challenges.Proteins2005
12784363Weighted geometric docking: incorporating external information in the rotation-translation scan.Proteins2003
12784366Prediction of the unknown: inspiring experience with the CAPRI experiment.Proteins2003
12784363Weighted geometric docking: incorporating external information in the rotation-translation scan.Proteins2003
12643769Prediction of the structure of the complex between the 30S ribosomal subunit and colicin E3 via weighted-geometric docking.J Biomol Struct Dyn2003
12643769Prediction of the structure of the complex between the 30S ribosomal subunit and colicin E3 via weighted-geometric docking.J Biomol Struct Dyn2003
12784366Prediction of the unknown: inspiring experience with the CAPRI experiment.Proteins2003
12423788On the interaction of colicin E3 with the ribosome.Biochimie2002
12423788On the interaction of colicin E3 with the ribosome.Biochimie2002
12324462The RNA helicase DbpA exhibits a markedly different conformation in the ADP-bound state when compared with the ATP- or RNA-bound states.J Biol Chem2002
12324462The RNA helicase DbpA exhibits a markedly different conformation in the ADP-bound state when compared with the ATP- or RNA-bound states.J Biol Chem2002
10556552Phage display of a cellulose binding domain from Clostridium thermocellum and its application as a tool for antibody engineering.J Immunol Methods1999
10556552Phage display of a cellulose binding domain from Clostridium thermocellum and its application as a tool for antibody engineering.J Immunol Methods1999
  • 1 - 44 of 44

Recommended Authors

The Weizmann Institute of Science
Career Start Year 2007
Number of shared co-authors 22
University of Pittsburgh
Career Start Year 2006
Number of shared co-authors 0
Institute of Bioengineering, Ecole Polytechnique Federale de Lausanne
Career Start Year 2006
Number of shared co-authors 7
The State University of New Jersey
Career Start Year 2003
Number of shared co-authors 5
College of Biotechnology and Bioengineering, Zhejiang University of Technology
Career Start Year 2001
Number of shared co-authors 2
Incyte Corporation
Career Start Year 2000
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 0
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1999
Number of shared co-authors 6
Weizmann Institute of Science
Career Start Year 1996
Number of shared co-authors 2
Indian Institute of Science Education and Research Pune
Career Start Year 1996
Number of shared co-authors 2
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 3
Weizmann Institute of Science
Career Start Year 1995
Number of shared co-authors 2
Tel Aviv University
Career Start Year 1991
Number of shared co-authors 36
University of Pittsburgh
Career Start Year 1990
Number of shared co-authors 22
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Career Start Year 1990
Number of shared co-authors 1
Fox Chase Cancer Center
Career Start Year 1989
Number of shared co-authors 23
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1989
Number of shared co-authors 4
University of Virginia
Career Start Year 1989
Number of shared co-authors 3
Institut fur Pharmazeutische Chemie, Philipps-Universitat Marburg
Career Start Year 1988
Number of shared co-authors 2
Albert Einstein College of Medicine
Career Start Year 1988
Number of shared co-authors 3
Leiden Academic Centre for Drug Research (LACDR), Leiden University
Career Start Year 1988
Number of shared co-authors 1
University of Washington
Career Start Year 1988
Number of shared co-authors 43
Boston University
Career Start Year 1987
Number of shared co-authors 0
Abo Akademi University
Career Start Year 1985
Number of shared co-authors 1
Cambridge Institute for Medical Research, University of Cambridge
Career Start Year 1982
Number of shared co-authors 5
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year 1981
Number of shared co-authors 3
Institute for Protein Research, Osaka University
Career Start Year 1980
Number of shared co-authors 40
Heartand Lung Research Institute, University of Cambridge
Career Start Year 1971
Number of shared co-authors 4
Albert Einstein College of Medicine
Career Start Year 1968
Number of shared co-authors 5
Vanderbilt University
Career Start Year 1954
Number of shared co-authors 7

Collaborators

Weizmann Institute of Science
Co-authored papers 7
Co-authored papers 1
Amgen Inc.
Co-authored papers 1
King Abdullah University of Science and Technology (KAUST)
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Deqing Hospital of Traditional Chinese Medicine
Co-authored papers 1
VIB-VUB Center for Structural Biology
Co-authored papers 1
University of Massachusetts Medical School
Co-authored papers 1
Interdisciplinary Research Center HALOmem, Martin Luther University Halle-Wittenberg
Co-authored papers 1
Qiagen Inc.
Co-authored papers 1
Center for Advanced Computation, Korea Institute for Advanced Study
Co-authored papers 1
University of Washington
Co-authored papers 1
The University of Kansas
Co-authored papers 1
International University of Health and Welfare (IUHV Hospital)
Co-authored papers 1
Co-authored papers 1
University of Mauritius
Co-authored papers 1
Heidelberg Institute for Theoretical Studies (HITS)
Co-authored papers 1
Rady Children's Institute for Genomic Medicine
Co-authored papers 1
Co-authored papers 1
Dalton Cardiovascular Research Center, University of Missouri
Co-authored papers 1
Boston University
Co-authored papers 1
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 1
MGH/Harvard Medical School
Co-authored papers 1
Utrecht University
Co-authored papers 1
GSK Medicines Research Centre
Co-authored papers 1
Center for Molecular Biology (ZMBH), Heidelberg University
Co-authored papers 1
Korea Institute for Advanced Study
Co-authored papers 1
Universite de Lorraine, CNRS
Co-authored papers 1
Utrecht University
Co-authored papers 1
Utrecht University
Co-authored papers 1